Os Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (Tadc)-Based Therapeutic Candidates
Os Therapies宣佈開發了兩個新穎的可調節抗體藥物結合物(Tadc)療法候選品
Os Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (Tadc)-Based Therapeutic Candidates
Os Therapies宣佈開發了兩個新穎的可調節抗體藥物結合物(Tadc)療法候選品
譯文內容由第三人軟體翻譯。